ListedSMEMedical Equipment/Supplies/AccessoriesAAKAAR

Aakaar Medical Technologies IPO

Aakaar Medical Technologies IPO is a sme IPO raising ₹27 Cr at ₹68 – ₹72 a share. It listed on 27 Jun 2025 and trades at ₹68 today, −5.6% against its issue price of ₹72. It was subscribed 0.00× in total.

72
Issue price
68
Price now
−5.6%
Since issue price
27 Jun 2025
Listed on
0.00×Subscribed (final) · all exchanges

No bids yet

populated partly populated we hold nothing here — the tab says why

How its cohort has done

265 SME issues listed in 2025 that we can price today. This is the group this issue belongs to.

−10.6%
Median return since issue price
57.7%
Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

How the book finished

The category split is the number worth reading, not the total.

QIB0.00×
Non-institutional0.00×
Retail0.00×

QIB: 0.00× their allocation. QIB: 0.00×.

See the full split, sub-category by sub-category →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidQIB, non-institutional and retail, with sub-splits
How demand built over timeOnly one reading so far; the series builds as bidding runs
Price-point demand curveLive only — NSE stops serving this once bidding closes
Lead managers and registrar1 bank
Official documents4 documents
Performance since listingComputed from our own daily closes

What happens when

18 Jun 2025Pre-apply opens
20 Jun 2025Bidding opens
24 Jun 2025Bidding closes
26 Jun 2025Allotment finalised — you find out what you got
26 Jun 2025Money refunded to unsuccessful bidders
27 Jun 2025Shares list and start trading
5 Aug 2025UPI mandate expires

Track AAKAAR MEDICAL TECHNO LTD

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.